Infectious Diseases 1602 - Infectious Disease Alert - Feb 01, 2012

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editors
Stan Deresinski, MD, FACP, FIDSA
Clinical Professor of Medicine
Stanford University
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

David J. Pierson, MD, Editor
Professor Emeritus
Pulmonary and Critical Care Medicine
University of Washington
Seattle

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Section Editor Updates
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewers
Timothy Jenkins, MD
Assistant Professor of Medicine
br / University of Colorado
Denver Health Medical Center

William Thompson, MD
Associate Professor of Medicine
University of Washington
Seattle

Associate Editors
Hal B. Jenson, MD, FAAP
Dean, Western Michigan University School of Medicine
Kalamazoo, Michigan

Jessica C. Song, M.A., Pharm.D
Clinical Supervisor of Pharmacy and Therapeutics
Ambulatory Care, and Mental Health
Santa Clara Valley Medical Center
San Jose, CA

Ellen Jo Baron, PhD, D(ABMM)
Professor of Pathology and Medicine
Stanford University
Medical School Director
Clinical Microbiology Laboratory
Stanford University School of Medicine

Dean L. Winslow, MD, FACP, FIDSA
Chief, Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine

Authors
Brenda Le
Pharmacy Department Volunteer
Santa Clara Valley Medical Center

Paul Hsiao
Pharm D
Pharmacist Specialist in the Purchasing Division
Santa Clara Valley Medical Center
Department of Pharmacy

Subjects:

  • Respiratory infections drive inappropriate antibiotic use in ambulatory pediatrics
  • Telaprevir, Boceprevir for HCV: High Cost may warrant 'criteria for use' policies
  • Severe Sepsis and Septic Shock in 2012: What Have We Learned?
  • The Globalization of Antibiotic Resistance — India and Cambodia
  • Absence of pathogens in intestinal tissue of patients with necrotizing enterocolitis
  • Updates

Objectives:

  • discuss the diagnosis and treatment of infectious diseases
  • explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Financial Disclosure:

Infectious Disease Alert's Editor, Stan Deresinski, MD, FACP, FIDSA, does research for the National Institutes of Health, and is an advisory board member and consultant for Merck. Updates Author Carol A. Kemper, MD, FACP, does research for Abbott Laboratories, and Merck. Editor David J. Pierson, MD, Editor, Peer Reviewers Timothy Jenkins, MD, William Thompson, MD, Associate Editors Hal B. Jenson, MD, FAAP, Jessica C. Song, M.A., Pharm.D., Authors Brenda Le, and Paul Hsiao report no financial relationship relavent to this field of study. Author Ellen Jo Baron, PhD, D(ABMM), is a co-founder and Secretary-Treasurer of Diagnostic Microbiology Development Program, a non-profit corporation that builds laboratory capacity in the resource-poor world. Associate Editor Dean L. Winslow, MD, FACP, FIDSA, is a speaker for Cubist Pharmaceuticals and GSK, and is a consultant for Siemens Diagnostics.

Copyright 2012 AHC Media. All rights reserved.